Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

First cohort dosed in phase I study of OMS-527

July 18, 2018

The locus of alcohol's reward

June 29, 2018

Omeros obtains approvals to begin phase I trial with PDE7 inhibitor OMS-527

June 28, 2018

DSMB of Aladote phase Ib/IIa study to treat paracetamol poisoning finds no safety concerns

June 25, 2018

Braeburn resubmits CAM-2038 NDA for opioid use disorder to FDA

May 28, 2018

FDA approves Lucemyra to mitigate opioid withdrawal symptoms

May 17, 2018

New phase II proof-of-concept trial studies IXT-m200 in methamphetamine users

May 11, 2018

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

FDA clears Pluristem's IND application for PLX-R18 to treat acute radiation syndrome

May 2, 2018

Accelerator Life Science Partners launches Proniras

April 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...